These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 28621057)

  • 1. Prospective evaluation of toceranib phosphate in metastatic canine osteosarcoma.
    Laver T; London CA; Vail DM; Biller BJ; Coy J; Thamm DH
    Vet Comp Oncol; 2018 Mar; 16(1):E23-E29. PubMed ID: 28621057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrospective evaluation of toceranib (Palladia) treatment for canine metastatic appendicular osteosarcoma.
    Kim C; Matsuyama A; Mutsaers AJ; Woods JP
    Can Vet J; 2017 Oct; 58(10):1059-1064. PubMed ID: 28966355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Toceranib/Piroxicam/Cyclophosphamide Maintenance Therapy on Outcome of Dogs with Appendicular Osteosarcoma following Amputation and Carboplatin Chemotherapy: A Multi-Institutional Study.
    London CA; Gardner HL; Mathie T; Stingle N; Portela R; Pennell ML; Clifford CA; Rosenberg MP; Vail DM; Williams LE; Cronin KL; Wilson-Robles H; Borgatti A; Henry CJ; Bailey DB; Locke J; Northrup NC; Crawford-Jakubiak M; Gill VL; Klein MK; Ruslander DM; Thamm DH; Phillips B; Post G
    PLoS One; 2015; 10(4):e0124889. PubMed ID: 25923466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of carboplatin and toceranib phosphate on serum vascular endothelial growth factor (VEGF) and metalloproteinase-9 (MMP-9) levels and survival in canine osteosarcoma.
    Gieger TL; Nettifee-Osborne J; Hallman B; Johannes C; Clarke D; Nolan MW; Williams LE
    Can J Vet Res; 2017 Jul; 81(3):199-205. PubMed ID: 28725110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary evidence for biologic activity of toceranib phosphate (Palladia(®)) in solid tumours.
    London C; Mathie T; Stingle N; Clifford C; Haney S; Klein MK; Beaver L; Vickery K; Vail DM; Hershey B; Ettinger S; Vaughan A; Alvarez F; Hillman L; Kiselow M; Thamm D; Higginbotham ML; Gauthier M; Krick E; Phillips B; Ladue T; Jones P; Bryan J; Gill V; Novasad A; Fulton L; Carreras J; McNeill C; Henry C; Gillings S
    Vet Comp Oncol; 2012 Sep; 10(3):194-205. PubMed ID: 22236194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of alternating administration of carboplatin and doxorubicin in dogs with microscopic metastases after amputation for appendicular osteosarcoma: 50 cases (1999-2006).
    Bacon NJ; Ehrhart NP; Dernell WS; Lafferty M; Withrow SJ
    J Am Vet Med Assoc; 2008 May; 232(10):1504-10. PubMed ID: 18479240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo effects of toceranib phosphate on canine osteosarcoma cell lines and xenograft orthotopic models.
    Sánchez-Céspedes R; Accornero P; Miretti S; Martignani E; Gattino F; Maniscalco L; Gola C; Iussich S; Martano M; Morello E; Buracco P; Aresu L; Maria R
    Vet Comp Oncol; 2020 Mar; 18(1):117-127. PubMed ID: 31816142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective evaluation of canine heart base tumours treated with toceranib phosphate (Palladia): 2011-2018.
    Lew FH; McQuown B; Borrego J; Cunningham S; Burgess KE
    Vet Comp Oncol; 2019 Dec; 17(4):465-471. PubMed ID: 31069932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Toceranib Phosphate in the Treatment of Canine Bladder Tumors: 37 Cases.
    Gustafson TL; Biller B
    J Am Anim Hosp Assoc; 2019; 55(5):243-248. PubMed ID: 31433219
    [No Abstract]   [Full Text] [Related]  

  • 10. STEALTH liposome-encapsulated cisplatin (SPI-77) versus carboplatin as adjuvant therapy for spontaneously arising osteosarcoma (OSA) in the dog: a randomized multicenter clinical trial.
    Vail DM; Kurzman ID; Glawe PC; O'Brien MG; Chun R; Garrett LD; Obradovich JE; Fred RM; Khanna C; Colbern GT; Working PK
    Cancer Chemother Pharmacol; 2002 Aug; 50(2):131-6. PubMed ID: 12172978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-agent pamidronate for palliative therapy of canine appendicular osteosarcoma bone pain.
    Fan TM; de Lorimier LP; O'Dell-Anderson K; Lacoste HI; Charney SC
    J Vet Intern Med; 2007; 21(3):431-9. PubMed ID: 17552447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maintenance therapy with toceranib following doxorubicin-based chemotherapy for canine splenic hemangiosarcoma.
    Gardner HL; London CA; Portela RA; Nguyen S; Rosenberg MP; Klein MK; Clifford C; Thamm DH; Vail DM; Bergman P; Crawford-Jakubiak M; Henry C; Locke J; Garrett LD
    BMC Vet Res; 2015 Jun; 11():131. PubMed ID: 26062540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant carboplatin and gemcitabine combination chemotherapy postamputation in canine appendicular osteosarcoma.
    McMahon M; Mathie T; Stingle N; Romansik E; Vail D; London C
    J Vet Intern Med; 2011; 25(3):511-7. PubMed ID: 21488959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of single-agent chemotherapy for treatment of clinically evident osteosarcoma metastases in dogs: 45 cases (1987-1991).
    Ogilvie GK; Straw RC; Jameson VJ; Walters LM; Lafferty MH; Powers BE; Withrow SJ
    J Am Vet Med Assoc; 1993 Jan; 202(2):304-6. PubMed ID: 8428842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pasteurized tumoral autograft and adjuvant chemotherapy for the treatment of canine distal radial osteosarcoma: 13 cases.
    Morello E; Vasconi E; Martano M; Peirone B; Buracco P
    Vet Surg; 2003; 32(6):539-44. PubMed ID: 14648532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective evaluation of toceranib phosphate (Palladia®) use in the treatment of inoperable, metastatic, or recurrent canine pheochromocytomas: 5 dogs (2014-2017).
    Musser ML; Taikowski KL; Johannes CM; Bergman PJ
    BMC Vet Res; 2018 Sep; 14(1):272. PubMed ID: 30176869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of P16 expression in canine appendicular osteosarcoma.
    Murphy BG; Mok MY; York D; Rebhun R; Woolard KD; Hillman C; Dickinson P; Skorupski K
    BMC Vet Res; 2017 Jun; 13(1):189. PubMed ID: 28633676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicity and efficacy of cisplatin and doxorubicin combination chemotherapy for the treatment of canine osteosarcoma.
    Chun R; Garrett LD; Henry C; Wall M; Smith A; Azene NM
    J Am Anim Hosp Assoc; 2005; 41(6):382-7. PubMed ID: 16267062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Weight Change During Carboplatin Therapy in Dogs With Appendicular Osteosarcoma.
    Story AL; Boston SE; Kilkenny JJ; Singh A; Woods JP; Culp WTN; Skorupski KA; Lu X
    J Vet Intern Med; 2017 Jul; 31(4):1159-1162. PubMed ID: 28503759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulse-Administered Toceranib Phosphate Plus Lomustine for Treatment of Unresectable Mast Cell Tumors in Dogs.
    Burton JH; Venable RO; Vail DM; Williams LE; Clifford CA; Axiak-Bechtel SM; Avery AC; Thamm DH
    J Vet Intern Med; 2015; 29(4):1098-104. PubMed ID: 26119008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.